Atlas Trials

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Clinical trial NCT03029611 · TERMINATED

Trial details

NCT number
NCT03029611
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Primary Peritoneal Cancer
Start date
2017-04-03
Primary completion
2018-10-17
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.